Switching from Lexapro (Escitalopram) to Luvox (Fluvoxamine)
When switching from escitalopram to fluvoxamine, use a direct switch approach: start fluvoxamine at a low dose (25-50 mg at bedtime) on the same day you stop escitalopram, then titrate fluvoxamine slowly over 4-7 days while monitoring closely for serotonin syndrome symptoms, especially in the first 24-48 hours. 1, 2
Switching Strategy
The guideline evidence supports cautious direct switching between SSRIs rather than requiring a washout period (which is only necessary for MAOIs). 1 Here's the specific approach:
Step 1: Stop Escitalopram
- Taper escitalopram gradually if the patient has been on it for an extended period to minimize discontinuation syndrome (dizziness, fatigue, nausea, anxiety, irritability). 3
- Escitalopram has minimal effect on CYP450 enzymes, making it relatively straightforward to switch from. 1
Step 2: Initiate Fluvoxamine
- Start fluvoxamine at 25-50 mg once daily at bedtime (lower than the typical 50 mg starting dose for adults). 2
- This low starting dose is critical because you're introducing a second serotonergic drug. 1
Step 3: Titration Schedule
- Increase fluvoxamine by 50 mg increments every 4-7 days as tolerated, targeting 100-300 mg/day for adults (maximum 300 mg/day). 2
- For doses above 100 mg/day, split into two divided doses with the larger dose at bedtime. 2
Critical Safety Monitoring
Monitor intensively for serotonin syndrome in the first 24-48 hours after starting fluvoxamine and after each dose increase. 1 Watch for:
- Mental status changes: confusion, agitation, anxiety
- Neuromuscular hyperactivity: tremors, clonus, hyperreflexia, muscle rigidity
- Autonomic hyperactivity: hypertension, tachycardia, diaphoresis, shivering, vomiting, diarrhea
- Advanced symptoms: fever, seizures, arrhythmias, unconsciousness (medical emergency)
Important Considerations
Drug Interaction Risk
Fluvoxamine has significantly greater potential for drug-drug interactions than escitalopram because it inhibits multiple CYP450 enzymes (CYP1A2, CYP2C19, CYP2C9, CYP3A4, and CYP2D6). 1 Review all concurrent medications before switching, particularly:
- Drugs metabolized by these enzymes
- Medications that prolong QT interval
- Other serotonergic agents
Discontinuation Syndrome Risk
Both escitalopram and fluvoxamine can cause discontinuation syndrome, though fluvoxamine carries higher risk than escitalopram. 1 The direct switch approach minimizes this risk by maintaining serotonergic activity throughout the transition.
Pharmacokinetic Interaction
Research shows that fluvoxamine significantly increases escitalopram plasma concentrations (by approximately 87% in one study) through CYP2C19 inhibition. 4 If any overlap occurs during the switch, use the lowest possible doses and monitor closely.
Common Pitfalls to Avoid
Do NOT use a 14-day washout period - this is only required when switching to/from MAOIs, not between SSRIs. 3
Do NOT start fluvoxamine at full therapeutic doses - the guideline explicitly recommends starting the second serotonergic drug at a low dose. 1
Do NOT ignore the increased drug interaction potential - fluvoxamine affects far more drug-metabolizing enzymes than escitalopram. 1
Do NOT skip the close monitoring window - symptoms of serotonin syndrome typically arise within 24-48 hours of combining serotonergic medications. 1